Asthma
Odds for repeat surgery for CRSwNP rise with extensive surgery, antibiotic use, asthma
In patients with chronic rhinosinusitis with nasal polyps, factors including baseline antibiotic use and asthma impacted the odds for revision endoscopic sinus surgery, according to data published in Clinical and Translational Allergy.
Age, corticosteroid use impact asthma attack risk in women using progesterone-only pill
The risk for asthma attacks significantly rose among women using a progesterone-only contraceptive pill who were younger than age 35 years or had low corticosteroid use, according to data published in ERJ Open Research.
Fixed-dose albuterol-budesonide inhaler lowers severe exacerbation risk in mild asthma
SAN FRANCISCO — In patients with uncontrolled mild asthma, a fixed-dose combination of albuterol and budesonide used as an as-needed treatment vs. albuterol alone lowered the risk for severe asthma exacerbations, according to trial data.
Risks for new-onset adverse outcomes fall with biologic treatment for asthma
SAN FRANCISCO — Patients who begin biologic treatment for severe asthma have fewer new-onset adverse outcomes than those who do not begin biologics, according to a poster presented at the American Thoracic Society International Conference.
About half of patients with severe asthma taking tezepelumab quit daily corticosteroids
SAN FRANCISCO — About half of patients with asthma on tezepelumab had discontinued their daily maintenance oral corticosteroid doses by 52 weeks, according to an abstract presented at the American Thoracic Society International Conference.
Women with asthma face elevated risk for fertility treatment
The risk for fertility treatment rose among women with vs. without asthma, and those with severe asthma and past exacerbations faced a greater risk, according to data published in The Journal of Allergy and Clinical Immunology: In Practice.
Peak expiratory flow recommended as first-line test in asthma diagnosis
SAN FRANCISCO — Physicians can use peak expiratory flow as a first-line tool for assessing variable airflow limitations among patients with asthma, according to a poster presented at the American Thoracic Society International Conference.
Low persistence in biologic therapy linked to asthma exacerbations, steroid use
SAN FRANCISCO — Patients with asthma who did not persist with biologic treatment had more exacerbations and used more oral corticosteroids, according to an abstract presented at the American Thoracic Society International Conference.
Lung function improves for patients with asthma within 24 hours with rademikibart
SAN FRANCISCO — Patients with moderate to severe asthma saw increases in FEV1 within 24 hours after taking a loading dose of rademikibart, according to an abstract presented at the American Thoracic Society International Conference.
